Search

Your search keyword '"Raiees Andrabi"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Raiees Andrabi" Remove constraint Author: "Raiees Andrabi"
101 results on '"Raiees Andrabi"'

Search Results

1. Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes

2. High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunization

3. Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge.

4. Evolution of antibody immunity following Omicron BA.1 breakthrough infection

5. High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike

6. Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus

7. Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron

8. The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2

9. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit

10. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies

11. Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways

12. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection

13. An Automated Fluorescence-Based Method to Isolate Bone Marrow-Derived Plasma Cells from Rhesus Macaques Using SIVmac239 SOSIP.664

14. Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies

15. Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer

16. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model

17. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein

18. Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIVsmm/mac Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization

19. The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template

20. Reprogramming the antigen specificity of B cells using genome-editing technologies

22. Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual.

23. Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India.

24. Broad-Spectrum Heavily Mutated Monoclonal Antibody Isolated from COVID-19 Convalescent Vaccinee with Capacity to Neutralize SARS-CoV2 Variants Ranging from B.1 to BQ.1.1

25. Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift

26. Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes

27. Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning

28. A germline-targeting chimpanzee SIV envelope glycoprotein elicits a new class of V2-apex directed cross-neutralizing antibodies

29. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike

30. Evolution of antibody immunity following Omicron BA.1 breakthrough infection

31. A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs

32. The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2

33. Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques

34. Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses

35. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike

37. A broad and potent neutralization epitope in SARS-related coronaviruses

38. An Automated Fluorescence-Based Method to Isolate Bone Marrow-Derived Plasma Cells from Rhesus Macaques Using SIVmac239 SOSIP.664

39. Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies

40. Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape

41. The Effects of an mRNA Covid-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans

42. Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus

43. A recurring YYDRxG pattern in broadly neutralizing antibodies to a conserved site on SARS-CoV-2, variants of concern, and related viruses

44. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit

45. Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques

46. The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template

47. A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection

48. Site-specific steric control of SARS-CoV-2 spike glycosylation

49. Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site

50. Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization

Catalog

Books, media, physical & digital resources